atezolizumab - Robuta Search

https://www.cigna.com/knowledge-center/hw/medications/atezolizumab-and-hyaluronidase-tqjs-injection-a624074 Atezolizumab and hyaluronidase-tqjs Injection | Cigna Atezolizumab and hyaluronidase-tqjs injection is used alone or with other chemotherapy medications to treat certain types of non-small cell lung cancer... hyaluronidase tqjs atezolizumab injection cigna https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-of-atezolizumab-and-tiragolumab-for-lung-cancer-skyscaper-03 A trial of atezolizumab and tiragolumab for lung cancer (SKYSCAPER-03) This trial is comparing two treatments for non small cell lung cancer. The first treatment is atezolizumab and tiragolumab. The other treatment is durvalumab. a trial lung cancer atezolizumab https://www.hmpgloballearningnetwork.com/site/onc/news/ttfields-plus-atezolizumab-and-chemotherapy-improves-disease-control-metastatic TTFields Plus Atezolizumab and Chemotherapy Improves Disease Control in Metastatic Pancreatic Cancer Results from the phase 2 PANOVA-4 trial demonstrated that first-line treatment with TTFields plus atezolizumab and chemotherapy achieved a higher disease... https://www.macmillan.org.uk/cancer-information-and-support/treatments-and-drugs/atezolizumab-and-bevacizumab Atezolizumab and bevacizumab | Macmillan Cancer Support Atezolizumab and bevacizumab is a combination of 2 different cancer drugs. This treatment is used to treat primary liver cancer. macmillan cancer atezolizumab bevacizumab support https://www.spandidos-publications.com/10.3892/ol.2025.15229 Radiomics-based prediction of HCC response to atezolizumab/bevacizumab Oncology Letters is an international journal devoted to Experimental and Clinical Oncology. radiomics based prediction hcc response https://www.uhhospitals.org/uh-research/find-clinical-trials-and-studies/clinical-trials-search/iadademstat-with-atezolizumab-or-durvalumab-at-improving-outcomes-for-sclc-24277 Iadademstat, With Atezolizumab or Durvalumab at Improving Outcomes for SCLC * | University Hospitals A Phase I Dose Finding and Phase II Randomized Trial of Iadademstat Combined With Immune Checkpoint Inhibition Maintenance After Initial Chemoimmunotherapy in... https://www.mayo.edu/research/clinical-trials/cls-20432226 Study Of Cabozantinib Alone Or In Combination With Atezolizumab To Subjects With Locally Advanced... Learn more about services at Mayo Clinic. https://www.mayo.edu/research/clinical-trials/cls-20391800?p=1 Open-Label Study of PEGPH20 With CIS and GEM; PEGPH20 With Atezolizumab, CIS and GEM; and Compared... open label study https://www.mskcc.org/cancer-care/clinical-trials/24-228 A Phase 1b/2 Study of Ifinatamab Deruxtecan Plus Atezolizumab With or Without Carboplatin in People... Full Title A Phase 1b/2, Multicenter, Open-label Study of Ifinatamab Deruxtecan (I-DXd), A B7-H3 Antibody-Drug Conjugate (ADC), in Combination with... https://www.cancerresearchuk.org/about-cancer/treatment/drugs/atezolizumab-nab-paclitaxel Atezolizumab and nab-paclitaxel | Cancer Research UK Atezolizumab and nab-paclitaxel are a combination of cancer drugs for the treatment of triple negative breast cancer. Find out about how you about having it... nab paclitaxel cancer research atezolizumab uk https://www.mayo.edu/research/clinical-trials/cls-20391800 Open-Label Study of PEGPH20 With CIS and GEM; PEGPH20 With Atezolizumab, CIS and GEM; and Compared... Learn more about services at Mayo Clinic. open label study https://www.cancerresearchuk.org/about-cancer/treatment/drugs/atezolizumab-bevacizumab Atezolizumab and bevacizumab | Cancer information | Cancer Research UK Atezolizumab and bevacizumab are cancer drugs. It is a treatment for hepatocellular carcinoma (HCC). Find out about side effects and more. cancer information atezolizumab bevacizumab research uk https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-at-atezolizumab-for-people-with-head-and-neck-cancer Cancer Research UK | A trial looking at atezolizumab for people with head and neck cancer It is for people who have completed initial treatment for their head and neck cancer and have a high risk of the cancer coming back or getting worse. cancer research uk https://www.mayo.edu/research/clinical-trials/cls-20467385 A Study to Evaluate Chemoradiotherapy with or without Atezolizumab in Treating Patients With... Learn more about services at Mayo Clinic. a study https://www.biospace.com/affimed-receives-fast-track-designation-for-combination-therapy-of-afm24-with-atezolizumab-for-egfr-wild-type-non-small-cell-lung-cancer Affimed Receives Fast Track Designation for Combination Therapy of AFM24 with Atezolizumab for EGFR... May 29, 2024 - Affimed N.V. announced that the FDA has granted Fast Track designation to the combination of its innate cell engager AFM24 with atezolizumab for the treatment... fast track designation https://www.cancer.gov/about-cancer/treatment/drugs/atezolizumab?ref=thesustainableinvestor.org.uk Atezolizumab - NCI Atezolizumab works by binding to the protein PD-L1 on the surface of some cancer cells, which keeps cancer cells from suppressing the immune system. This... atezolizumab nci https://www.einpresswire.com/article/317597249/genmab-announces-studies-of-daratumumab-in-combination-with-atezolizumab-in-a-solid-tumor-and-multiple-myeloma Genmab Announces Studies of Daratumumab in Combination with Atezolizumab in a Solid Tumor and... Mar 21, 2016 - Company Announcement Phase Ib studies of daratumumab in combination with Roche's immune checkpoint inhibitor atezolizumab in a solid tumor and multiple myeloma https://www.dana-farber.org/clinical-trials/17-727 A Phase 2 Study of Anti-PD-L1 Antibody (Atezolizumab) in Alveolar Soft Part Sarcoma | Dana-Farber... This phase II trial studies how well atezolizumab or atezolizumab plus bevacizumab works in treating patients with alveolar soft part sarcoma that has not been... https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2025.1349645/full Frontiers | Cost-effectiveness of atezolizumab versus chemotherapy in patients with non-small-cell... BackgroundAtezolizumab has recently demonstrated improved prognosis in patients with advanced or metastatic non-small-cell lung cancer (NSCLC) who are not el... https://www.hmpgloballearningnetwork.com/site/onc/videos/impact-subcutaneous-formulation-atezolizumab-treatment-patients-certain-solid How Atezolizumab Subcutaneous Changes Treatment The US FDA approved the subcutaneous formulation of atezolizumab for patients with NSCLC, SCLC, HCC, melanoma, and alveolar soft part sarcoma. atezolizumab subcutaneous changes treatment https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-adding-radiotherapy-to-atezolizumab-for-people-with-urothelial-urinary-tract-cancer-that-has-spread-rearm A trial looking at adding radiotherapy to atezolizumab for people with urothelial (urinary tract)... This trial is looking at adding radiotherapy to a drug called atezolizumab. It is for people with urinary tract cancer that has spread to somewhere else. https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-lurbinectedin-combination-atezolizumab-or-atezolizumab-and-hyaluronidase-tqjs-extensive FDA approves lurbinectedin in combination with atezolizumab or atezolizumab and hyaluronidase-tqjs... On October 2, 2025, the Food and Drug Administration approved lurbinectedin (Zepzelca, Jazz Pharmaceuticals, Inc.) in combination with atezolizumab (Tecentriq,... fda approves lurbinectedin combination https://www.biospace.com/roche-encouraged-by-mid-stage-atezolizumab-bladder-cancer-data Roche Encouraged by Mid-Stage Atezolizumab Bladder Cancer Data - BioSpace bladder cancer roche encouraged mid stage https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-of-lurbinectedin-and-atezolizumab-to-improve-treatment-for-small-cell-lung-cancer-imforte A trial of lurbinectedin and atezolizumab to improve treatment for small cell lung cancer (IMforte) This trial is looking at adding lurbinectedin to atezolizumab to help treat small cell lung cancer (SCLC). https://www.cincinnatichildrens.org/service/c/clinical-trials/studies/VITAS-052124 VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01119 Testing the Drug Atezolizumab or Placebo with Usual Therapy in First-Line HER2-Positive Metastatic... Testing the Drug Atezolizumab or Placebo with Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-of-atezolizumab-with-standard-treatment-for-diffuse-b-cell-lymphoma-argo A trial of atezolizumab with standard treatment for diffuse B cell lymphoma (ARGO) This trial is looking at whether atezolizumab can improve treatment for a people with a type of non-Hodgkin lymphoma called diffuse B cell lymphoma (DBCL). https://www.fda.gov/drugs/drug-approvals-and-databases/fda-approves-atezolizumab-pd-l1-positive-unresectable-locally-advanced-or-metastatic-triple-negative FDA approves atezolizumab for PD-L1 positive unresectable locally advanced or metastatic... On March 8, 2019, the Food and Drug Administration granted accelerated approval to atezolizumab (TECENTRIQ, Genentech Inc.) in combination with paclitaxel... pd l1 https://www.tga.gov.au/news/news-articles/lapse-provisional-registration-tecentriq-atezolizumab-treatment-locally-advanced-or-metastatic-triple-negative-breast-cancer-mtnbc Lapse of provisional registration for Tecentriq (atezolizumab) for the treatment of locally... Apr 14, 2026 - Provisional registration of Tecentriq (atezolizumab) for the treatment in mTNBC will lapse on 22 March 2023. provisional registration the treatment lapse tecentriq atezolizumab https://pmc.ncbi.nlm.nih.gov/articles/PMC12497873/ Transarterial chemoembolization plus atezolizumab and bevacizumab in patients with intermediate... Transarterial chemoembolization (TACE) is the standard treatment for intermediate-stage hepatocellular carcinoma (HCC), yet its efficacy as a standalone... in patients chemoembolization plus atezolizumab bevacizumab https://www.mdanderson.org/patients-family/diagnosis-treatment/clinical-trials/clinical-trials-index/clinical-trials-detail.ID2016-0861.html A Phase II, Single-Arm Open-Label Study Of The Combination Of Atezolizumab And Bevacizumab In Rare... This phase II trial studies how well atezolizumab and bevacizumab work in treating patients with rare solid tumors. Immunotherapy with monoclonal antibodies,... https://www.mountsinai.org/clinical-trials/study-evaluating-atezolizumab-with-without-bevacizumab-in-participants-with-unresectable-hepatocellular-carcinoma-child-pugh-b7-b8-cirrhosis A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable... a study evaluating atezolizumab https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-atezolizumab-cabozantinib-non-small-cell-lung-cancer-spread-contact-01 A trial looking at atezolizumab and cabozantinib for non small cell lung cancer that has spread... This trial is comparing atezolizumab and cabozantinib with docetaxel for people with non small cell lung cancer. non small cell lung cancer https://www.nice.org.uk/guidance/ta584 Overview | Atezolizumab in combination for treating metastatic non-squamous non-small-cell lung... Evidence-based recommendations on atezolizumab (Tecentriq) with bevacizumab (Avastin), carboplatin and paclitaxel for metastatic non-squamous non-small-cell https://www.hmpgloballearningnetwork.com/site/onc/conference-coverage/first-line-atezolizumab-improved-survival-compared-chemotherapy Atezolizumab as First-Line Therapy for NSCLC Phase 3 trial finds atezolizumab improved outcomes for patients with NSCLC compared to chemotherapy. first line therapy atezolizumab nsclc https://www.mayo.edu/research/clinical-trials/cls-20468270 A Study of Taxane, Trastuzumab, and Pertuzumab With or Without Atezolizumab in Treating Metastatic... Learn more about services at Mayo Clinic. https://pmc.ncbi.nlm.nih.gov/articles/PMC12657762/ Lenvatinib vs. sorafenib as second-line treatment post atezolizumab plus bevacizumab for... Atezolizumab plus bevacizumab (A+B) is a standard first-line systemic therapy for unresectable hepatocellular carcinoma (HCC). However, optimal sequencing... second line treatment https://www.cancerresearchuk.org/about-cancer/treatment/drugs/atezolizumab Atezolizumab (Tecentriq) | Cancer information | Cancer Research UK Atezolizumab is an immunotherapy for bladder, urinary system or non small cell lung cancer (NSCLC). Find out how you have it, possible side effects and other... cancer information atezolizumab tecentriq research uk https://www.cancer.gov/about-cancer/treatment/drugs/atezolizumab-and-hyaluronidase-tqjs Atezolizumab and Hyaluronidase-tqjs - NCI Atezolizumab and hyaluronidase-tqjs works by binding to the protein PD-L1 on the surface of some cancer cells, which keeps cancer cells from suppressing the... hyaluronidase tqjs atezolizumab nci